Microbiota Dysbiosis and the Gut-Brain Axis in Psychiatric Disorders: Molecular Mechanisms, Clinical Evidence, and Therapeutic Perspectives
Alpha Psychiatry · 22.10.2026 · 27 (5)
DOI: 10.31083/ap54121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alpha Psychiatry, online erschienen am 22.10.2026. Verfasst von Giuseppe Marano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Head-Neck and Chest, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Ital…. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gut-brain axis provides a biologically plausible framework for understanding the bidirectional interactions among the intestinal microbiota, immune-inflammatory signaling, neuroendocrine regulation, neurotransmitter metabolism, and psychiatric symptoms. Although numerous recent reviews have examined individual psychiatric disorders, microbial composition, or microbiota-targeted therapies, the field still lacks a sufficiently integrated appraisal that clearly distinguishes associative findings from human studies, mechanistic evidence from preclinical research, and preliminary clinical interventions. This structured narrative review synthesizes clinical, translational, and preclinical studies across major depressive disorder, bipolar disorder, anxiety disorders, schizophrenia, and trauma-related conditions. The main literature search covered publications from January 2015 to January 2026; earlier foundational mechanistic studies of key relevance to gut–brain communication were also considered. Recurrent pathways include altered short-chain fatty acid production, tryptophan-kynurenine metabolism, immune-inflammatory activation, hypothalamic-pituitary-adrenal axis dysregulation, neurotransmitter-related signaling, impaired intestinal and blood-brain barrier integrity, and vagus nerve-mediated communication. Human studies predominantly demonstrate associations between microbial signatures and psychiatric phenotypes, symptom severity, inflammatory status, or treatment response, whereas preclinical models provide stronger mechanistic evidence that microbiota manipulation can influence behavioral, neurochemical, immune, and neuroendocrine outcomes. Probiotics, prebiotics, dietary interventions, and fecal microbiota transplantation show therapeutic potential; however, the current evidence is limited by small sample sizes, methodological heterogeneity, insufficient standardization, and a lack of long-term validation. The distinctive contribution of this review is its structured comparison of three levels of evidence—human observational findings, experimental mechanistic studies, and emerging clinical interventions—thereby clarifying what has been consistently replicated, what remains mechanistically plausible, and what is not yet ready for routine application in psychiatric practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience, Head-Neck and Chest, Section of Psychiatry, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
- Department of Neuroscience, Section of Psychiatry, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Unit of Medical Genetics, Department of Laboratory Medicine, Ospedale Isola Tiberina-Gemelli Isola, 00186 Rome, Italy.
- Spine Surgery Department, Bambino Gesù Children's Hospital IRCCS, 00168 Rome, Italy.
- Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
- Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
ORCID-Profile: Giuseppe Marano, Luca Conci, Leila Farsakh, Gianandrea Traversi, Osvaldo Mazza, Valentina Ricozzi, Silvia Rotondaro, Antonella Migliore, Esmeralda Capristo, Gianluca Franceschini, Eleonora Gaetani, Marianna Mazza
Zitieren
APA
Marano, G., Conci, L., Farsakh, L., Traversi, G., Mazza, O., Ricozzi, V., Rotondaro, S., Migliore, A., Capristo, E., Franceschini, G., Gaetani, E., & Mazza, M. (2026). Microbiota Dysbiosis and the Gut-Brain Axis in Psychiatric Disorders: Molecular Mechanisms, Clinical Evidence, and Therapeutic Perspectives. Alpha Psychiatry, 27(5). https://doi.org/10.31083/ap54121
Vancouver
Marano G, Conci L, Farsakh L, Traversi G, Mazza O, Ricozzi V, et al. Microbiota Dysbiosis and the Gut-Brain Axis in Psychiatric Disorders: Molecular Mechanisms, Clinical Evidence, and Therapeutic Perspectives. Alpha Psychiatry. 2026;27(5). doi:10.31083/ap54121
BibTeX
@article{Marano2026,
author = {Marano, Giuseppe and Conci, Luca and Farsakh, Leila and Traversi, Gianandrea and Mazza, Osvaldo and Ricozzi, Valentina and Rotondaro, Silvia and Migliore, Antonella and Capristo, Esmeralda and Franceschini, Gianluca and Gaetani, Eleonora and Mazza, Marianna},
title = {Microbiota Dysbiosis and the Gut-Brain Axis in Psychiatric Disorders: Molecular Mechanisms, Clinical Evidence, and Therapeutic Perspectives},
journal = {Alpha Psychiatry},
year = {2026},
volume = {27},
number = {5},
doi = {10.31083/ap54121}
}
EUVIMED